Status:
COMPLETED
Pilot Study Evaluating Feasibility and Benefits of Telemonitored NIV Treatment on COPD Patients
Lead Sponsor:
ResMed
Conditions:
COPD
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Pilot study evaluating feasibility and benefits of telemonitored NIV (noninvasive ventilation) treatment on COPD (chronic obstructive pulmonary disease) patients. Multicentric Randomized Controlled T...
Eligibility Criteria
Inclusion
- COPD patient already treated by NIV requiring therapy assessment in their routine care Follow-Up or
- COPD patient requiring de Novo NIV therapy according to routine care rules (NIV\<12h)
- Patient requiring NIV therapy by S9 VPAP ST +/- oxygen therapy
- Patient willing to participate to the study
- Patient or attendant able to complete patient passport and to come to Follow-Up visits.
Exclusion
- NIV therapy Failure during screening phase (intolerance, patient refusal, significant leaks, significant AHI or Oxymetry events)
- Hospitalization conducting to NIV discontinuation for at least 1 week during the screening phase
Key Trial Info
Start Date :
July 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2018
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT02258191
Start Date
July 1 2014
End Date
January 1 2018
Last Update
January 23 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital privé la Louvière
Lille, France, 59000